ACAD
Acadia Pharma (ACAD)
NASDAQ
$28.08+$0.25 (+0.88%)
Price as of Sep 11, 2026 7:34 PM EDT
  • $4.8B
    Market Cap
  • 17.87%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 84
Valuation
ACAD
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 72
Valuation
ACAD
vs History
vs S&P 500
3-Month Momentum
34.84%
12-Month Momentum
21.69%
3-Month Risk Adjusted Momentum
237.25%
12-Month Risk Adjusted Momentum
59.41%

True Yield

N/A
Valuation
ACAD
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 64
Valuation
ACAD
vs History
vs S&P 500
Ohlson's O-Score
10